CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cel... by Hongjie Wang, Theo Koob, Jonathan R. Fromm, Ajay Gopal, Darrick Carter, André Lieber

Subjects: Get full text

Treatment of double-refractory multiple myeloma by S. V. Semochkin

Subjects: Get full text

Comprehensive safety evaluation of isatuximab in multiple myeloma using disproportionality analysis of FAERS and meta-analysis of randomized controlled trials by Muhammed Favas Karimbanathottathil, Beema T Yoosuf, M Mamatha, Dipika Bansal

Subjects: “…Isatuximab…”
Get full text

Subcutaneous administration of isatuximab in patients with multiple myeloma by an on-body delivery system: results of a nurse survey by Nuria Sánchez Avello, Paula Calvo Pajares, Paul Cordero, Florence Suzan, Connie Barlas

Subjects: Get full text

Third-line multiple myeloma treatment of inpatients in a German cancer center: analysis of potential cost savings due to decreased renal insufficiency by F. Jakobs, P. Ahmadi, V. Osterkamp, J. Jeck, U. Holtick, C. Scheid, Florian Kron

Subjects: Get full text

Analysis of pharmacotherapeutic approaches for multiple myeloma and correlated renal and pulmonary impairments: a retrospective real-world registry study in the Greater Gulf Region... by Ayman Alhejazi, Ahmad Alhuraiji, Abdulnaser Nourallah, Abdulrahman Alshehri, Binyam Usman, Ghada ElGohary, Hafiz Malhan, Ibraheem Motabi, Ibraheem Motabi, Khalil Al Farsi, Mohammed Alshuaibi, Mohanad Diab, Mustaqeem Siddiqui, Ruba Yasin Taha, Tarek Abouzeid, Wesam Ahmed, Wesam Ahmed, Ahmed Ramadan Ali, Rasha Ghonema, Sana Faysal Elkhazin, Yousra Moussa, Abdullah M. Alrajhi, Abdullah M. Alrajhi, Magdy Rabea, Yahia Aktham, Nesreen Bawazeer, Ali Ahmed Ali, Mohamed Zahir Chouikrat

Subjects: Get full text

Efficacy of IsaPomDex triplet therapy in double refractory multiple myeloma patients in real clinical practice in Russia by M. V. Solovev, M. V. Solovevа, L. P. Mendeleeva, T. I. Pospelova, N. V. Skvortsova, S. V. Voloshin, A. D. Garifullin, A. S. Chuprakova, T. A. Mitina, I. S. Usankin, I. V. Vasileva, N. V. Medvedeva, V. V. Ryabchikova, M. Ya. Kiseleva, G. A. Dudina, Yu. S. Gammershmidt, O. S. Kuznetsova, Yu. V. Dolgushina, G. B. Kuchma, T. N. Tsyganok, E. N. Misyurina, E. I. Zhelnova, A. V. Kopylova, M. N. Zakharova, A. V. Korobkin, G. S. Tumyan, A. A. Semenova, E. G. Kirillova, E. M. Volodicheva, V. I. Bakhtina, T. I. Olkhovik, N. R. Solovkova, M. V. Demchenkova, O. E. Ochirova, O. L. Panteleeva, V. S. Abramova

Subjects: “…monoclonal antibody isatuximab…”
Get full text

Isatuximab in the treatment of refractory and relapsed multiple myeloma: literature review and case report by Yu. E. Ryabukhina, P. A. Zeynalova, F. M. Abbasbeyli, O. L. Timofeeva, T. T. Valiev, N. A. Kupryshina, A. G. Zhukov

Subjects: Get full text

Practice-changing updates on multiple myeloma: highlights from the 2024 ASH annual meeting by Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Maria Gavriatopoulou

Subjects: Get full text

Efficacy of Anti-CD38 Monoclonal Antibodies for Relapsed or Refractory Multiple Myeloma in Stem Cell Transplant-Ineligible Patients Aged over 65 Years: A Propensity Score-Matched S... by Satoshi Yamasaki, Michitoshi Hashiguchi, Nao Yoshida-Sakai, Hiroto Jojima, Koichi Osaki, Takashi Okamura, Yutaka Imamura

Subjects: Get full text

Comparison of 6 cycles of isatuximab with lenalidomide, bortezomib and dexamethasone (I-VRd) versus 3 cycles of I-VRd followed by one cycle of high-dose melphalan in newly diagnose... by Theo Leitner, Evgenii Shumilov, Christina Schwitlick, Raphael Koch, Franziska Hamm, Marion Högner, Florian Bassermann, Katja Weisel, Hermann Einsele, Martin Kortüm, Leo Rasche, Martin Görner, Kai Wegehenkel, Stefan Knop, Jan Krönke, Axel Nogai, Inke R. König, Maren Vens, Kay Horn, Nikolas von Bubnoff, Cyrus Khandanpour

Subjects: Get full text

A systematic review and meta-analysis of phase III randomized controlled trials to assess the risk of pneumonia, URTIs, and VTE in multiple myeloma patients treated with isatuximab by Daniel Thomas Jones, Hazem Aboaid, Ramaditya Srinivasmurthy, Kevin Nguyen, Rishi Kumar Nanda, Jason Ta, Benjamin Tzer-Ming Chuang, Yin Mon Myat, Aishwarya Hanspal, Kyaw Zin Thein, Thura Win Htut

Subjects: Get full text